A recent decision by the US Supreme Court may lead to increased legal action within the healthcare sector, says one expert. Federal Trade Commission deputy assistant director Sara Razi suggested that the Court’s decision, made last February, strengthened federal antitrust lawyers when clarifying when state antitrust law can trump federal; the Court unanimously agreed that “state-action immunity is disfavored” in FTC vs. Phoebe Putney Health System. The FTC sued the health group over a merger, approved by Georgia’s state hospital regulators. According to Razi, the ruling was “manna from heaven” and suggested that the Court’s ruling demonstrated unity between liberals and conservatives when it comes to federal antitrust exemptions. According to Razi, this may lead to more legal action taken within the healthcare sector as federals find the support of Supreme Court precedence.
Featured News
EU Set to Review Rival Netflix and Paramount Skydance Bids for Warner Bros. Discovery
Jan 21, 2026 by
CPI
Judge Tosses Drug Pricing Conspiracy Case Against CVS, UnitedHealth, Evernorth
Jan 21, 2026 by
CPI
House Panel Alleges CVS Used Contracts to Suppress Pharmacy Competition
Jan 21, 2026 by
CPI
AI Is Changing M&A as Regulators Target ‘Killer Acquisitions’ and Data Control
Jan 21, 2026 by
CPI
Epic Games Brings in Veteran Tech Lawyer as Legal Chief
Jan 21, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Recidivism
Jan 21, 2026 by
CPI
Recidivism, Multiple Offending, and Serial Offending in Antitrust
Jan 21, 2026 by
Gregory Werden
Antitrust Recidivism: Why Repeat Cases Appear, and Why True Reoffending Is Rare in the United States
Jan 21, 2026 by
Lisa M. Phelan, Megan S. Golden, Adrienne Irmer & Nina Worth
99 Antitrust Problems – Is Recidivism One?
Jan 21, 2026 by
Brian A. Ratner & Kartik S. Madiraju
Holding A Cat by the Tail: A View of Cartel Recidivism in U.S. Antitrust Enforcement
Jan 21, 2026 by
Mark & KaDee L. Ru